Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 3Phase NA 2Phase 3 2Phase 2/3 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Leukemia 41Breast Neoplasms 28Lymphoma 21Leukemia, Myeloid, Acute 16Burkitt Lymphoma 13Myelodysplastic Syndromes 11Graft vs Host Disease 10Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Biphenotypic, Acute 7Squamous Cell Carcinoma of Head and Neck 6Urinary Bladder Neoplasms 5Leukemia, Promyelocytic, Acute 5Hodgkin Disease 5Anemia, Refractory, with Excess of Blasts 5Osteosarcoma 4Myeloproliferative Disorders 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Chronic 4Head and Neck Neoplasms 4Arthritis, Rheumatoid 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

Doxorubicin 25Ifosfamide 22Radiotherapy 17Etoposide 11Vincristine 10Cyclophosphamide 10Filgrastim 8Dactinomycin 8Trabectedin 7Chemotherapy, Adjuvant 5pazopanib 4Cisplatin 4Topotecan 3Radiation 3Neoadjuvant Therapy 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3Dacarbazine 3sargramostim 2etoposide phosphate 2eribulin 2Observation 2Methotrexate 2Mesna 2Imatinib Mesylate 2Gemcitabine 2Epirubicin 2Docetaxel 2Dexrazoxane 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma × Methotrexate × Clear all
NCT00470223 2025-06-08

OS2006

UNICANCER

Phase 3 Active not recruiting
318 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT00003937 2014-08-05

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Children's Oncology Group

Phase 3 Completed
253 enrolled
Sarcoma

Sarcoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡